These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 358140)

  • 1. [The action of dihydroergotoxine in acute sickling crisis. Results of a double-blind study carried out in French speaking Africa (author's transl)].
    Begue P; Bertrand E; Bonhomme J; David M; Coullet Y; Pierredon M; Sankale M
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2449-52. PubMed ID: 358140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.
    Teuscher T; Von Der Ahe CW; Baillod P; Holzer B
    Trop Geogr Med; 1989 Oct; 41(4):320-5. PubMed ID: 2635446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):611-9. PubMed ID: 440964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of ticlopidine in sickle cell disease.
    Semple MJ; Al-Hasani SF; Kioy P; Savidge GF
    Thromb Haemost; 1984 Jul; 51(3):303-6. PubMed ID: 6388012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteonecrosis in drepanocytemia (author's transl)].
    Delahaye RP; Doury P; Pattin S; Metges PJ; Marchesseau JP
    Med Trop (Mars); 1978; 38(2):223-8. PubMed ID: 723569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Questions about the medical treatment of homozygotic drepanocytemia (author's transl)].
    Andre LJ
    Med Trop (Mars); 1978; 38(2):229-34. PubMed ID: 723570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F; Bejaoui M
    Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deapril-ST for senile dementia.
    Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sickle cell anemia].
    Meyer P
    Fortschr Med; 1976 Oct; 94(30):1726-31. PubMed ID: 992545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV
    J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW; Kennedy LD
    Ann Pharmacother; 1997 Nov; 31(11):1393-6. PubMed ID: 9391697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies.
    Guffanti E; Vaccarella A; Meregalli M; Fiorella G; Chierichetti SM; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):506-9. PubMed ID: 3902677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sickle cell disease in children. Value of hygergine in the treatment and prophylaxis of the crisis].
    Sanokho A; Martin L; Niang NK; Kuakuvi N
    Bull Soc Med Afr Noire Lang Fr; 1975; 20(1):83-9. PubMed ID: 820437
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises.
    Cabannes R; Lonsdorfer J; Castaigne JP; Ondo A; Plassard A; Zohoun I
    Agents Actions Suppl; 1984; 15():199-212. PubMed ID: 6385647
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diastolic function of the left ventricle in a North-African patient with homozygous sickle-cell anemia].
    Kingué S; Mbanya D; Tapko JB; Nguegno A; Ngu KB
    Ann Cardiol Angeiol (Paris); 2000 Sep; 49(6):351-61. PubMed ID: 12555347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1978; 20(4):611-9. PubMed ID: 752153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
    Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease.
    Kopecky EA; Jacobson S; Joshi P; Koren G
    Clin Pharmacol Ther; 2004 Mar; 75(3):140-6. PubMed ID: 15001964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.